GFAP, a component of the cytoskeleton of astrocytes, is upregulated during reactive astrocytosis, which has been associated with pathological changes in Alzheimer's disease and other neurodegenerative diseases and dementias [19, 21, 29]. Here, GFAP is linked to neurodegenerative disease.